🟢 Cerenome is trading 8% up in pre-market with no company-specific catalyst identified

Cerenome is trading 8.02% up at $2.69 after rising from the September 9 close of $2.49; the catalyst remains unclear.

• No company-specific announcement, earnings release, analyst action, or other fresh catalyst was identified for September 10; available market pages report no recent headlines.
• Healthcare is weaker pre-market, so the gain appears isolated rather than sector-driven.